Søgning på udtrykket 'ivermectin' giver 40 resultater


Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
BMC Infectious Diseases
23.07.2022
. Abstract. . Background. The role of ivermectin in the treatment of COVID-19 is still under debate, yet the drug has been widely used in some parts of the world, as shown by impressive market data. The available body of evidence may have changed over the last months, as studies have been retracted and “standards of care” (SOC) used in control groups have changed with rapidly evolving knowledge on COVID-19. This revi…
BMC Infectious Diseases
23.07.2022
. Abstract. . Background. The role of ivermectin in the treatment of COVID-19 is still under debate, yet the drug has been widely used in some parts of the world, as shown by impressive market data. The available body of evidence may have changed over the last months, as studies have been retracted and “standards of care” (SOC) used in control groups have changed with rapidly evolving knowledge on COVID-19. This revi…
Lancet Infectious Diseases
16.07.2022
In 2020, WHO recognised the importance of strongyloidiasis alongside soil-transmitted helminths (STH) in their 2021–30 roadmap, which aspires to target Strongyloides stercoralis with preventive chemotherapy by use of ivermectin. Combination treatment with both albendazole, the primary drug used to treat STH, and ivermectin, would improve the efficiency of mass drug administration targeting both STH and S stercoralis. In this Personal View, we discuss the challenges and opportunities towards the developmen…
International Journal of Infectious Diseases
16.06.2022
Introduction
PLoS One Infectious Diseases
12.05.2022
by Daniel Camprubí, Alex Almuedo-Riera, Helena Martí-Soler, Alex Soriano, Juan Carlos Hurtado, Carme Subirà, Berta Grau-Pujol, Alejandro Krolewiecki, Jose Muñoz.
American Journal of Tropical Medicine and Hygiene
10.05.2022
. . Journal Name: The American Journal of Tropical Medicine and HygieneVolume: 106Issue: 5_SupplPages: 18-25. .
American Journal of Tropical Medicine and Hygiene
10.05.2022
. . Journal Name: The American Journal of Tropical Medicine and HygieneVolume: 106Issue: 5_SupplPages: 26-28. .
American Journal of Tropical Medicine and Hygiene
10.05.2022
. . Journal Name: The American Journal of Tropical Medicine and HygieneVolume: 106Issue: 5_SupplPages: 48-55. .
Lancet Infectious Diseases
7.05.2022
Mass administration of the triple-drug regimen was more effective than the two-drug regimen in reducing microfilariae prevalence in communities to less than the target level of 1%, but did not reduce circulating filarial antigen prevalence to less than 2%. These results support the use of mass drug administration with the triple-drug regimen to accelerate elimination of lymphatic filariasis.
New England Journal of Medicine
30.03.2022
New England Journal of Medicine, Ahead of Print.
Clinical Microbiology and Infection
22.03.2022
There is an ongoing debate worldwide about the possible benefits of ivermectin for the treatment and prevention of COVID-19. Some advocacy groups concluded, based on limited, early studies, that ivermectin might be beneficial. They continuously lobby for the widespread use of ivermectin for the treatment and prevention of COVID-19, especially through social media. Based on their advice, some medical doctors of different specialties in many countries have recommended the use of ivermectin for COVID-19 treatm…
Malaria Journal
4.03.2022
… The STECLA strain of Anopheles albimanus has been in continuous colony for many years and is the reference strain on which genomic studies for the species are based. Recently, the STECLA strain was demonstrated to be much less susceptible to ivermectin ingested in a blood meal (4-day LC50 of 1468 ng/ml) than all other Anopheles species tested to-date (LC50 values range from 7 to 56 ng/ml). The ability of An. albimanus to survive ingestion of ivermectin at concentrations far beyond that typical…
PLoS One Infectious Diseases
10.02.2022
by Gebremedhin Gebrezgabiher, Delenasaw Yewhalaw, Mio Ayana, Asrat Hailu, Zeleke Mekonnen. . Community-directed treatment with ivermectin (CDTi) is the primary strategy employed to control and eliminate human onchocerciasis in Ethiopia. After long-term mass distribution for onchocerciasis, ivermectin is expected to have additional benefits beyond the envisioned targets by reducing the burden of other co-endemic parasitic infections as to STHs. To date, studies focused on the collateral impact of CDTi on S…
Journal of the American Medical Association
8.02.2022
This study examines insurer coverage of ivermectin prescriptions for COVID-19 in the US.
American Journal of Tropical Medicine and Hygiene
2.02.2022
. . Journal Name: The American Journal of Tropical Medicine and HygieneVolume: 106Issue: 2Pages: 700-709. .
American Journal of Tropical Medicine and Hygiene
2.02.2022
. . Journal Name: The American Journal of Tropical Medicine and HygieneVolume: 106Issue: 2Pages: 740-745. .
Clinical Microbiology and Infection
2.02.2022
Since the onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, various therapeutic agents have been repurposed to treat patients with coronavirus disease 2019 (COVID-19), and used empirically before adequate clinical studies were performed. One of the most controversial drugs in the very initial phase of the pandemic was hydroxychloroquine. This drug, which has been used to treat malaria, amebiasis and autoimmune diseases (e.g., systemic lupus erythematosus and rheumatoid arth…
Lancet Infectious Diseases
15.12.2021
Numerous malaria endemic areas have benefitted from substantial declines in malaria burden, raising the possibility of eventual elimination.1 Declines have been attributed to successful roll-out of effective control interventions including long-lasting insecticide-treated nets, indoor residual spraying with insecticides, prompt and accurate diagnosis, effective case management, active surveillance, and chemoprevention. Despite the marked decline in malaria burden observed between 2000 and 2015, progress in …
Lancet Infectious Diseases
15.12.2021
The intervention was safe and well tolerated. In an area with high coverage of standard control interventions, mass drug administration of ivermectin and dihydroartemisinin–piperaquine significantly reduced malaria prevalence; however, no effect of ivermectin on vector parous rate was observed.

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
11.05.2022
The article was part of a special issue of Toxicology Reports on COVID-19 that has received an expression of concern; six of the eight articles still have EoCs. .
Medscape Infectious Diseases
11.04.2022
Ivermectin neither reduced hospital admissions for worsening COVID-19 nor shortened the time that infected patients spent in the emergency room, according to data from a large randomized controlled trial. .
Medscape Infectious Diseases
31.03.2022
"Now that people can dive into the details and the data, hopefully that will steer the majority of doctors away from ivermectin towards other therapies." .
Medscape Infectious Diseases
22.03.2022
Researchers at McMaster University in Ontario studied around 1,358 COVID patients who were at risk for severe disease because they had diabetes or other conditions. .
Medscape Infectious Diseases
17.03.2022
The measure also would limit pharmacists' ability to refuse to fill prescriptions for the anti-worm treatment ivermectin and other drugs for off-label uses as COVID-19 treatments. .
Medscape Infectious Diseases
18.02.2022
"The study findings do not support the use of ivermectin for patients with COVID-19," study authors conclude. .
Medscape Infectious Diseases
18.02.2022
Rates of new hydroxychloroquine (HCQ) prescriptions particularly increased in highly Republican counties after the Food and Drug Administration revoked its EUA for the drug's use in treating COVID-19. .
Medscape Infectious Diseases
9.02.2022
Oklahoma's attorney general says his office has found no legal basis for medical boards to discipline doctors who prescribe ivermectin or hydroxychloroquine for COVID-19. .
Medscape Infectious Diseases
27.01.2022
'That is something between a doctor and a patient, on what their best way forward on care is,' said Kansas state Senate committee chair Richard Hilderband, on the prescribing of ivermectin for COVID-19. .
Medscape Infectious Diseases
24.01.2022
The study, which began last summer, is attempting to provide a comprehensive assessment of the controversial treatment. .
Medscape Infectious Diseases
19.01.2022
A PLOS journal has issued an expression of concern for a 2018 paper which claimed that ivermectin could be useful as a way to control dengue fever. .
Medscape Infectious Diseases
14.01.2022
Most prescriptions are being written for COVID-19, although there's no evidence that it's effective against the virus. .
Medscape Infectious Diseases
2.12.2021
Hospitals in Montana and Idaho reported threats and harassment from public officials and family members of patients who were denied treatment with a drug not authorized to treat COVID-19.
Medscape Infectious Diseases
8.11.2021
Hospitals and doctors are facing more demands for ivermectin as a covid-19 treatment. In some Republican-dominated states, pushing for ivermectin interventions has become a conservative rallying cry.
Medscape Infectious Diseases
3.11.2021
The authors of a study purportedly showing that ivermectin could treat patients with SARS-CoV-2 have retracted their paper after acknowledging that their data were garbled.
Medscape Infectious Diseases
18.10.2021
At least two dozen lawsuits have been filed around the US, many in recent weeks, by people seeking to force hospitals to give their COVID-stricken loved ones ivermectin.
Medscape Infectious Diseases
12.10.2021
Republican state lawmakers are urging easier access for Alaskans to ivermectin amid the pandemic, though ivermectin is not authorized by the FDA for preventing or treating COVID-19.
ProMED
22.09.2021
COVID-19 -- Worldwide/UnknownWHO region (no. countries/territories):Total confirmed cases (new cases in last 24 hours) / Total deaths (new deaths in last 24 hours)--------------------------------------------------------------------------------Western Pacific Region (19): 7 974 488 (60 114) / 108 643 (931)European Region (61): 68 419 751 (129 294) / 1 313 479 (2089)South East Asia Region (10): 42 547 959 (49 037) / 669 126 (658)Eastern Mediterranean Region (22): 15 480 394 (30 417) / 283 387 (676)Region of
Medscape Infectious Diseases
2.09.2021
Citing patient harm, the AMA and others call for immediate end to prescribing, dispensing, and use of ivermectin to prevent or treat COVID-19 outside of a clinical trial.
Medscape Infectious Diseases
31.08.2021
Another case, another state, another judge ordering a hospital to give a patient a controversial horse de-worming drug to treat a severe case of COVID-19.

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2022 Dansk Selskab for Infektionsmedicin

CVR: 33634307

version: 2.11.0 ● design: Christian Philip Fischer

Side indlæst på 0,554 s

Cookies og privatliv